Cerebroprotein hydrolysate attenuates neurodegenerative changes in Alzheimer’s mice model via ferroptosis pathway

Introduction: Cerebroprotein hydrolysate has been proven to improve cognitive function in patients with Alzheimer’s disease (AD). We explored the safety and effectiveness of the clinical administration of oral cerebroprotein hydrolysate in AD, and possible mechanisms related to the neuronal ferropto...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Moxi Chen, Wei Song, Zhengju Chen, Xiaodong Shi, Xue Wang, Rongrong Li, Honglin Hao, Wei Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-04-01
coleção:	Frontiers in Pharmacology
Assuntos:	Alzheimer’s disease ferroptosis oxidative stress cerebroprotein hydrolysate APP/PS1 mice
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1177503/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!